Vimarsana
Biggest News Aggregation in the World

Page 10 - Section Chief News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Section Chief. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Section Chief Today - Breaking & Trending Today

MIRDC Inaugurates Asia-Pacific Vacuum Heat Treatment Synergy Center, Advancing Taiwan's Precision Machinery Industry - Vimarsana News

MIRDC Inaugurates Asia-Pacific Vacuum Heat Treatment Synergy Center, Advancing Taiwan's Precision Machinery Industry

/PRNewswire/ -- The Metal Industries Research & Development Centre (MIRDC) and ECM Group jointly announced the establishment of the Asia-Pacific Vacuum Heat...

Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular ... - Vimarsana News

Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular ...

BRAINTREE, Mass., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced it has entered into a collaboration

Washington Healthcare Update - December 2023 #2 | McGuireWoods Consulting - Vimarsana News

Washington Healthcare Update - December 2023 #2 | McGuireWoods Consulting

This Week in Washington: House Energy and Commerce Committee markup includes 19 healthcare bills; Senate HELP Committee to mark up SUPPORT Act Reauthorization and three other bills;...

Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Sickle Cell Disease - Vimarsana News

Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Sickle Cell Disease

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) announced today that the U.S. Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 genome-edited cell therapy, for the treatment of sickle cell disease (SCD) in patients ...

Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY for the Treatment of Sickle Cell Disease - Vimarsana News

Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY for the Treatment of Sickle Cell Disease

BOSTON - Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics announced today that the U.S. Food and Drug Administration has approved CASGEVY , a CRISPR/Cas9 genome-edited cell therapy, for...